BioSpace News Archive

Grifols has been recognized among the world’s most sustainable companies by the Dow Jones Sustainability Index, the largest global sustainability index and an international benchmark for socially responsible investors.

Theralink Technologies (OTC: OBMP) (“Theralink” or the “Company”) , a precision oncology molecular profiling company with a novel phosphoprotein-based laboratory developed test (LDT), today announced its partnership with Perthera , a market leader in Precision Oncology technology and services. The alliance will facilitate and accele

Alzamend Neuro®, Inc. (“Alzamend®” or the “Company”) reminds shareholders, investors and all interested parties that mandatory registration is closing Tuesday morning for the conference call and webcast to be held that day November 17th at 5:00pm ET (2:00pm PT) led by Alzamend’s Founder and Chairman, Milton “Todd” Ault, III, and Stephan Jackman, Alzamend’s CEO and Director.

Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Stifel Virtual Healthcare Conference on Tuesday, November 17, 2020 at 2:40 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (Nasdaq: MASI) is a global medica

OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, and Almalence Inc., one of the world’s leaders in computational imaging, today announced at CompaMed a joint solution that eliminates the conflict between camera size and resolution found in current medical imaging solutions.

Revelation Biosciences Inc. (Revelation), a clinical stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease, announced today that the first cohort of its Phase 1 clinical study of REVTx‑99 in healthy volunteers (RVL‑NHV01 study) has completed dosing. Eight study participants were dosed with REVTx-9

Moberg Pharma’s subsidiary OncoZenge has received binding undertakings regarding a directed issue of shares of SEK 10 million and a fully secured rights issue of shares of approximately SEK 60 million.

Covis Group S.à r.l. announced the completion of its acquisition of AMAG Pharmaceuticals, Inc. through the successful tender offer for all of the outstanding shares of common stock of AMAG at $13.75 per share in cash and subsequent merger.

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based therapeutic formulations and medicines, announced today that it has established a subsidiary, Digestix Bioscience Inc., a company dedicated to the development of medical devices and pharmace

Appointment is the Latest in a Focused Talent Strategy to Optimize Long-Term Shareholder Value and Build Recurring Revenue Base With Over 35 Patents and Patent Applications on Preclinical and Clinical Technologies, Company Seeks to Explore Out-Licensing and Collaborative Development Deals